|
|
|
41
|
5951D
|
PREDNISOLONE 1% EYE DR (FSB)
|
PREDNISOLONE
|
PREDNISOLONE
|
5ML
|
A
|
4
|
3.9959
|
BOTT
|
1
|
BOTT
|
FSB
|
FLAGSHIP BIOTECH
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
5208
|
EENT ANTI-INFLAMMATORY AGENTS
|
2024-04-01
|
2026-03-31
|
|
OPHTHALMIC
|
6
|
EENT ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
42
|
5951F
|
PREDPLUS 1% EYE DR (SYP) PREDNISOLONE
|
PREDNISOLONE
|
PREDPLUS
|
10ML
|
A
|
1.98
|
1.98
|
BOTT
|
1
|
BOTT
|
SYP
|
SYAASH PHARMACEUTICALS
|
PSB
|
PHARMACEUTICAL SOLUTIONS BARBA
|
|
5208
|
EENT ANTI-INFLAMMATORY AGENTS
|
2026-04-01
|
|
|
OPHTHALMIC
|
6
|
EENT ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
40
|
59532
|
MINIMS PREDNISOLONE 0.5% (CHA/STO)
|
PREDNISOLONE
|
MINIMS PREDNISOLONE
|
20X0.5ML
|
B
|
94.71
|
4.74
|
EYE DROP
|
0
|
AMP
|
CHA
|
CHAUVIN PHARMACEUTICAL LTD
|
STO
|
BRYDEN STOKES LTD
|
|
5208
|
EENT ANTI-INFLAMMATORY AGENTS
|
2022-04-01
|
2024-03-31
|
|
OPHTHALMIC
|
0
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
40
|
59612
|
JANUMET 500MG | 50MG TAB (MSD/STO) METFORMIN | SITAGLIPTIN
|
METFORMIN|SITAGLIPTIN
|
JANUMET
|
56'S
|
C
|
70.65
|
1.26
|
TABLET
|
0
|
TAB
|
MSD
|
MERCK SHARP & DOHME (I.A.) CORP
|
STO
|
BRYDEN STOKES LTD
|
|
682005
|
DIPEPTIDYL PEPTIDASE INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
|
|
|
|
41
|
59612
|
JANUMET 500MG|50MG TAB (MSD) METFORMIN|SITAGLIPTIN (C)
|
METFORMIN|SITAGLIPTIN
|
JANUMET
|
56'S
|
C
|
70.65
|
1.2616
|
TAB
|
0
|
BOX
|
MSD
|
MERCK SHARP & DOHME (I.A.) CORP
|
STO
|
BRYDEN STOKES LTD
|
|
682005
|
DIPEPTIDYL PEPTIDASE INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
DIPEPTIDYL PEPTIDASE INHIBITORS
|
|
|
|
|
40
|
59613
|
GALVUSMET 500MG | 50MG TAB (NVS/COL) METFORMIN | VIDAGLIPTIN
|
METFORMIN|VIDAGLIPTIN
|
GALVUSMET
|
56'S
|
B
|
32.62
|
0.58
|
TABLET
|
60
|
TAB
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
B
|
682005
|
DIPEPTIDYL PEPTIDASE INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
|
|
|
|
41
|
59613
|
GALVUSMET 500MG|50MG TAB (NVS) METFORMIN|VILDAGLIPTIN (B)
|
METFORMIN|VILDAGLIPTIN
|
GALVUSMET
|
56'S
|
B
|
32.62
|
0.5825
|
TAB
|
60
|
BOX
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
682005
|
DIPEPTIDYL PEPTIDASE INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
DIPEPTIDYL PEPTIDASE INHIBITORS
|
|
|
|
|
42
|
59613
|
GALVUSMET 500MG|50MG TAB (NVS) METFORMIN|VILDAGLIPTIN
|
METFORMIN|VILDAGLIPTIN
|
GALVUSMET
|
56'S
|
C
|
27.18
|
0.49
|
TAB
|
60
|
BLIS
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
AVENTA BARBADOS
|
|
682005
|
DIPEPTIDYL PEPTIDASE INHIBITORS
|
2026-04-01
|
|
|
ORAL
|
0
|
DIPEPTIDYL PEPTIDASE INHIBITORS
|
|
|
|
|
40
|
59617
|
KOMBIGLYZE 1G | 2.5MG TAB (AZN/COL) METFORMIN | SAXAGLIPTIN
|
METFORMIN|SAXAGLIPTIN
|
KOMBIGLYZE
|
28'S
|
C
|
51.65
|
1.84
|
TABLET
|
0
|
TAB
|
AZN
|
ASTRAZENECA AB
|
COL
|
COLLINS LTD
|
|
682005
|
DIPEPTIDYL PEPTIDASE INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
|
|
|
|
42
|
5961L
|
METFOR SITA EZE 500MG|50MG TAB (INF) METFORMIN|SITAGLIPTIN
|
METFORMIN|SITAGLIPTIN
|
METFOR SITA EZE
|
10X10
|
C
|
15.66
|
0.16
|
TAB
|
0
|
BLIS
|
INF
|
INFOCUS REMEDIES PVT
|
RXP
|
RX PRO INC
|
|
682005
|
DIPEPTIDYL PEPTIDASE INHIBITORS
|
2026-04-01
|
|
|
ORAL
|
0
|
DIPEPTIDYL PEPTIDASE INHIBITORS
|
|
|
|
|
42
|
5961N
|
VILDALION-M 500MG|50MG TAB (STL) METFORMIN|VILDAGLIPTIN
|
METFORMIN|VILDAGLIPTIN
|
VILDALION-M
|
60'S
|
B
|
4.68
|
0.08
|
TAB
|
60
|
BLIS
|
STL
|
STALLION LABORATORIES
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
B
|
682005
|
DIPEPTIDYL PEPTIDASE INHIBITORS
|
2026-04-01
|
|
|
ORAL
|
6
|
DIPEPTIDYL PEPTIDASE INHIBITORS
|
|
|
|
|
40
|
59623
|
GALVUSMET 850MG | 50MG TAB (NVS/COL) METFORMIN | VIDAGLIPTIN
|
METFORMIN|VIDAGLIPTIN
|
GALVUSMET
|
56'S
|
B
|
32.62
|
0.58
|
TABLET
|
60
|
TAB
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
B
|
682005
|
DIPEPTIDYL PEPTIDASE INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
|
|
|
|
41
|
59623
|
GALVUSMET 850MG|50MG TAB (NVS) METFORMIN|VILDAGLIPTIN (B)
|
METFORMIN|VILDAGLIPTIN
|
GALVUSMET
|
56'S
|
B
|
32.62
|
0.5825
|
TAB
|
60
|
BOX
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
682005
|
DIPEPTIDYL PEPTIDASE INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
DIPEPTIDYL PEPTIDASE INHIBITORS
|
|
|
|
|
42
|
59623
|
GALVUSMET 850MG|50MG TAB (NVS) METFORMIN|VILDAGLIPTIN
|
METFORMIN|VILDAGLIPTIN
|
GALVUSMET
|
56'S
|
C
|
27.18
|
0.49
|
TAB
|
60
|
BLIS
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
AVENTA BARBADOS
|
|
682005
|
DIPEPTIDYL PEPTIDASE INHIBITORS
|
2026-04-01
|
|
|
ORAL
|
0
|
DIPEPTIDYL PEPTIDASE INHIBITORS
|
|
|
|
|
42
|
5962A
|
TRAJENTAMET 2.5MG|850MG TAB (BOE) LINAGLIPTIN|METFORMIN
|
LINAGLIPTIN|METFORMIN
|
TRAJENTAMET
|
60'S
|
C
|
114.66
|
1.91
|
TAB
|
0
|
BLIS
|
BOE
|
BOEHRINGER INGELHEIM
|
STO
|
BRYDEN STOKES LTD
|
|
682005
|
DIPEPTIDYL PEPTIDASE INHIBITORS
|
2026-04-01
|
|
|
ORAL
|
0
|
DIPEPTIDYL PEPTIDASE INHIBITORS
|
|
|
|
|
42
|
5962C
|
METFORMIN|VILDAGLIPTIN 850MG|50MG TAB (CHC)
|
METFORMIN|VILDAGLIPTIN
|
METFORMIN|VILDAGLIPTIN
|
60'S
|
B
|
21.31
|
0.36
|
TAB
|
60
|
|
CHC
|
CARITAS HEALTHCARE PVT LTD
|
STO
|
BRYDEN STOKES LTD
|
B
|
682005
|
DIPEPTIDYL PEPTIDASE INHIBITORS
|
2026-04-01
|
|
Add to Contract as Cat B
|
ORAL
|
6
|
DIPEPTIDYL PEPTIDASE INHIBITORS
|
2026-03-05
|
|
|
|
40
|
59632
|
JANUMET 1G | 50MG TAB (MSD/STO) METFORMIN | SITAGLIPTIN
|
METFORMIN|SITAGLIPTIN
|
JANUMET
|
56'S
|
C
|
70.65
|
1.26
|
TABLET
|
0
|
TAB
|
MSD
|
MERCK SHARP & DOHME (I.A.) CORP
|
STO
|
BRYDEN STOKES LTD
|
|
682005
|
DIPEPTIDYL PEPTIDASE INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
|
|
|
|
41
|
59632
|
JANUMET 1G|50MG TAB (MSD) METFORMIN|SITAGLIPTIN (C)
|
METFORMIN XR|SITAGLIPTIN
|
JANUMET XR
|
56'S
|
C
|
70.65
|
1.2616
|
TAB
|
0
|
BOX
|
MSD
|
MERCK SHARP & DOHME (I.A.) CORP
|
STO
|
BRYDEN STOKES LTD
|
|
682005
|
DIPEPTIDYL PEPTIDASE INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
DIPEPTIDYL PEPTIDASE INHIBITORS
|
|
|
|
|
40
|
59633
|
GALVUSMET 1G | 50MG TAB (NVS/COL) METFORMIN | VIDAGLIPTIN
|
METFORMIN|VIDAGLIPTIN
|
GALVUSMET
|
56'S
|
B
|
32.62
|
0.58
|
TABLET
|
60
|
TAB
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
B
|
682005
|
DIPEPTIDYL PEPTIDASE INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
|
|
|
|
41
|
59633
|
GALVUSMET 1G|50MG TAB (NVS) METFORMIN|VILDAGLIPTIN (B)
|
METFORMIN|VILDAGLIPTIN
|
GALVUSMET
|
56'S
|
B
|
29.9
|
0.534
|
TAB
|
60
|
BOX
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
682005
|
DIPEPTIDYL PEPTIDASE INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
DIPEPTIDYL PEPTIDASE INHIBITORS
|
|